Cervarix link to UK girl's death "unlikely"
This article was originally published in Scrip
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.
EllaOne (ulipristal acetate), HRA Pharma's emergency contraceptive, was approved for EU marketing in May under the centralised procedure, and the company is building a commercial presence throughout Europe to handle its launch.